Can Buying Protagonist Therapeutics Inc (NASDAQ: PTGX) Still Be Worthwhile?

Protagonist Therapeutics Inc (NASDAQ:PTGX) does about 742.64K shares in volume on a normal day but saw 731774 shares change hands in Tuesday trading. The company now has a market cap of 1.63B USD. Its current market price is $27.99, marking a decrease of -1.03% compared to the previous close of $28.28. The 52 week high […]